Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Sutro Biopharma, Inc. (STRO)

Biological Products, (no Disgnostic Substances)

https://www.sutrobio.com

Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/27/2018

Market Cap

345,067,177

Shares Outstanding

60,950,000

Weighted SO

60,953,204

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.2220

Last Div

0.0000

Range

2.01-6.13

Chg

0.1700

Avg Vol

825972

Mkt Cap

345067177

Exch

NASDAQ

Country

US

Phone

650 881 6500

DCF Diff

4.3168

DCF

-0.1368

Div Yield

0.0000

P/S

2.0375

EV Multiple

-4.3325

P/FV

2.2471

Div Yield %

0.0000

P/E

-2.7477

PEG

-0.0712

Payout

0.0000

Current Ratio

3.4117

Quick Ratio

3.4117

Cash Ratio

0.6984

DSO

14.9785

DIO

0.0000

Op Cycle

14.9785

DPO

316.3923

CCC

-301.4137

Gross Margin

0.9585

Op Margin

-0.6267

Pretax Margin

-0.6306

Net Margin

-0.7348

Eff Tax Rate

-0.1814

ROA

-0.2545

ROE

-0.9719

ROCE

-0.2956

NI/EBT

1.1653

EBT/EBIT

1.0062

EBIT/Rev

-0.6267

Debt Ratio

0.3493

D/E

1.1226

LT Debt/Cap

0.5186

Total Debt/Cap

0.5289

Int Coverage

-21.6299

CF/Debt

-0.4374

Equity Multi

3.2137

Rec Turnover

24.3682

Pay Turnover

1.1536

Inv Turnover

0.0000

FA Turnover

4.2609

Asset Turnover

0.3463

OCF/Share

-0.9199

FCF/Share

-0.9564

Cash/Share

5.2446

OCF/Sales

-0.4412

FCF/OCF

1.0398

CF Coverage

-0.4374

ST Coverage

-10.7769

CapEx Coverage

-25.1484

Div&CapEx Cov

-25.1484

P/BV

2.2471

P/B

2.2471

P/S

2.0375

P/E

-2.7477

P/FCF

-4.4418

P/OCF

-4.5767

P/CF

-4.5767

PEG

-0.0712

P/S

2.0375

EV Multiple

-4.3325

P/FV

2.2471

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation